How to achieve a healthy development cycle in the domestic LED industry
Domestic small and medium-sized LED companies are actually suffering from financing difficulties. After years of accumulation, these companies are eager to become bigger and stronger, but they have to wait quietly or even force Liangshan to borrow high-interest loans because of the lack of funds. Don't you see, recently another LED industrial base has reported that a company with an output of over 100 million has run away due to a broken capital chain.
At present, more than 95% of the 7,000 or 8,000 LED users in China are still small, medium and micro-sized. From the perspective of the circulation of payment in the industrial chain, if the user has a "high fever", the middle and upper reaches will definitely "catch the wind", and due to the collection of accounts Concerns about risks, the middle and upper reaches will also accelerate the collection of payment for goods, and the downstream funds will become more serious.
After all, we are all looking forward to subsidies and support for LED terminals from the national level, but the capital is limited, and the release will only benefit the local LED oligarchs. Even more difficult, the five-year subsidy peak period is about to pass away, and the differentiation pattern that the stronger is stronger and the weaker is weaker has been formed and continuously stabilized in the context of local administrative maintenance.
Five years ago, perhaps few people would believe that LEDs can dominate the field of lighting sources; five years later, few people should doubt that LEDs now represent the future of lighting. In this quasi-LED era of self-improvement, whether to stimulate "blood production" or disguised "blood transfusion" is not only related to the livelihood and development of some LED companies, but also the question of whether the domestic LED industry can achieve a healthy blood circulation.
Fortunately, in addition to relying on "blood transfusion", we still have several areas to make a fuss about: gathering single product breakthroughs, continuous technological micro-innovation, positioning differentiation competition, cost-effective products, establishing multiple channels, and leveraging e-commerce to reach terminal consumption Wait. In the future, these may be the chips with the most "hematopoietic" value.
